These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6573322)

  • 1. Clinical evaluation of cefotetan in the treatment of lower respiratory tract infections.
    Nolen TM; Phillips HL; Hall HJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():233-6. PubMed ID: 6573322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report on a comparative trial of cefotetan and cefoxitin in the treatment of urinary tract infections.
    Cox CE; Childs SJ; Wells WG; Mirelmant S; Lesky WC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():227-32. PubMed ID: 6341350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan in complicated urinary tract infections--clinical experience.
    Hautmann R; Pranada F; Pusztai-Markos Z
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():223-6. PubMed ID: 6573321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double-blind clinical study on cefotetan and cefmetazole in treating respiratory tract infections].
    Jpn J Antibiot; 1983 Feb; 36(2):316-68. PubMed ID: 6343663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with cefotetan in the treatment of infections of children].
    Nagamatsu I; Okuno H; Takase A; Tachibana K
    Jpn J Antibiot; 1983 Jun; 36(6):1199-203. PubMed ID: 6581326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy].
    Gaillat J; Croize J; Bru JP; Stahl JP; Le Noc P; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):461-4. PubMed ID: 3534722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of cefotetan in pediatrics].
    Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1983 Jun; 36(6):1271-8. PubMed ID: 6581332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies of T-1982 (cefbuperazone) in pediatric field].
    Aoyama R; Waga S; Ohnishi A; Izumi Y
    Jpn J Antibiot; 1983 Apr; 36(4):736-8. PubMed ID: 6876375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum and sputum levels of cefotetan used in respiratory tract infections].
    Matsumoto Y; Hitsuda Y; Sugimoto Y; Ishikawa J; Sasaki T
    Jpn J Antibiot; 1986 Oct; 39(10):2690-4. PubMed ID: 3468274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with rational cefotetan therapy in in situ and associated surgical infections].
    Puleo S; Li Destri G; Scuderi M; Sammartino R; Romeo MA; Gismondo MR; Nicoletti G
    Ann Ist Super Sanita; 1987; 23(4):911-3. PubMed ID: 3482980
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cooperative studies on clinical effect of cefotetan for severe infections combined with hematologic disorders].
    Shinohara Y; Matsubuchi T; Kawagoe H; Nagai K; Kanamaru A; Horiuchi A; Hasegawa H; Kitani T; Tsubakio T; Yonezawa T; Masaoka T; Shibata H
    Jpn J Antibiot; 1983 Feb; 36(2):391-7. PubMed ID: 6574264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of T-1982 (cefbuperazone) in children].
    Okada T; Fukukawa S
    Jpn J Antibiot; 1983 Apr; 36(4):862-8. PubMed ID: 6876376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.
    Lewis RT; Duma RJ; Echols RM; Jemsek JG; Najem AZ; Press RA; Stone HH; Ton GT; Wilson SE
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):728-35. PubMed ID: 3281463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotetan in the treatment of obstetric and gynecologic infections.
    Poindexter AN; Sweet R; Ritter M
    Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of cefotetan in pediatrics].
    Meguro H; Ozawa S; Togo T; Kim B; Arimasu O; Yonezawa H; Fujii R
    Jpn J Antibiot; 1983 Jun; 36(6):1262-70. PubMed ID: 6581331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamental and clinical studies on T-1982 (cefbuperzone), a new cephamycin antibiotic, in the field of pediatrics].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K; Irino Y; Nakada Y; Yoshihara T
    Jpn J Antibiot; 1983 Apr; 36(4):771-89. PubMed ID: 6308296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laboratory and clinical studies of T-1982 (cefbuperazone) in pediatrics].
    Sekiguchi T; Ichioka T; Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1983 Apr; 36(4):869-76. PubMed ID: 6348341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.